Drug profile

The FDA adverse-event record for Progesterone; Estradiol Benzoate

54 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Progesterone; Estradiol Benzoate. See the species affected, top reactions, and outcomes below.

54
adverse-event reports
27.8%
death-coded share
Cattle
most-reported species
11
Death - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
54
Total Reports
15
Deaths Reported
27.8%
Death Rate

Active Ingredients

Progesterone; Estradiol Benzoate

Administration Routes

UnknownSubcutaneous

Species Affected

Cattle 32
Unknown 21
Human 1

Most Affected Breeds

Unknown 22
Cattle (other) 10
Mixed (Cattle) 9
Holstein-Friesian also known as Holstein 6
Aberdeen Angus 5
Cattle (unknown) 1
Hereford cattle 1

Most Reported Reactions

Death 11
No sign 7
Increased sexual interest 7
Lack of efficacy (bacteria) - NOS 6
Implant, Abnormal 6
Containers, Damaged 5
Uncoded sign 4
Underfilling, Package 4
Lack of efficacy - NOS 3
Anaphylactic-type reaction 3
Sexual disorder NOS (see 'Reproductive' for named sexual disorders) 3
Joint swelling 2

Outcome Breakdown

Outcome Unknown
16 (36.4%)
Died
15 (34.1%)
Recovered/Normal
7 (15.9%)
Recovered with Sequela
3 (6.8%)
Ongoing
2 (4.5%)
Euthanized
1 (2.3%)

Progesterone; Estradiol Benzoate Adverse Event Insights

54 reports name Progesterone; Estradiol Benzoate; 15 recorded a death outcome (27.8% of reported events, not a population-level mortality rate). Active ingredient: Progesterone; Estradiol Benzoate. Administration routes: Unknown, Subcutaneous.

By species: Cattle (32 reports), Unknown (21 reports), Human (1 reports). By breed: Unknown (22), Cattle (other) (10), Mixed (Cattle) (9).

Leading clinical signs: Death (11), No sign (7), Increased sexual interest (7), Lack of efficacy (bacteria) - NOS (6). Outcome, 44 coded reports: Outcome Unknown leads at 36.4%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.